Solid Biosciences Inc. — Director's Dealing 2024

Dec 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-12-02

Reporting Person: Howton David T (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-02	Common Stock	M	13051	—	Acquired	20735	Direct
2024-12-03	Common Stock	S	5072	$5.5986	Disposed	15663	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-02	Restricted Stock Units	$	M	13051	Disposed		Common Stock (13051)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Howton.

F3: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.